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ABSTRACT 
 
Methotrexate is a folic acid antagonist, it works by inhibiting the dihydrofolate by interfering with the DNA 
synthesis. Ectopic pregnancy is a life threatening condition that may cause maternal mortality. The main 
aim of this review to show the efficacy of systemic methotrexate and shows the importance of methotrexate 
treatment in management of ectopic pregnancy with surgical treatment and dosage regimen with protocol 
treatment. The selection criteria of candidates in this review is pregnant women with <5000miu/ml, adrenal 
mass <4cm, presence of peritoneum <100mland no sign of cardiac activity. Data collections are made from 
most relevant article between the periods of 1987-2020. Ectopic pregnancy is an emergency condition if not 
timely diagnosed and most of the cases where identified in first trimester. 
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INTRODUCTION 
Ectopic pregnancy is the implantation of fertilized 
ovum on any tissue outside the uterine cavity [1]. It is 
acute emergency if not treated in right time. Mainly 
ectopic pregnancies are occurred in fallopian tube, 
ovary and cervix [2]. About more than 98% ectopic 
pregnancies are occurred in fallopian tube [3]. Ectopic 
pregnancy cause increased rate of mortality and 
morbidity [4,5]. The common symptoms include 
internal bleeding, abdominal pain, and amenorrhea 
[6]. Mainly ectopic pregnancies are occurred due to 
the obstruction of fallopian tube and pelvic 
inflammatory disease, in many cases the ectopic 
pregnancies are misdiagnosed, it is diagnosed by 
history of pelvic inflammatory disease, physical 
examination, measurement of β-hcg level with 
transvaginal ultrasonography [7]. Pregnancy of 
unknown location (PUL) is the preferred terminology 
when the serum hcg is positive, but no signs of 
intrauterine or extra uterine pregnancy can be 
detected using transvaginal ultrasonography and the 
main management of ectopic pregnancy includes 
surgical management and medical treatment [8]. 
Ectopic pregnancies are primarily managed by 
surgical procedure includes laparoscopic 
management and salpingectomy and now medical 
treatment are available [9,2,8]. Ectopic pregnancy is 
very dangerous for pregnant women, if the fertilized 
egg grows, they will eventually rupture the organ that 
contains it, and this will cause severe life threatening 
bleeding inside the body. Women have an ectopic 
pregnancy may cause a delay or variation in their 
menstrual periods, Women who experience 
incomplete abortion have long periods of 
amenorrhea [6]. Now a days the rate of ectopic 
pregnancies were increased and its mortality rate 
was decreased from the use of methotrexate [8]. 
Methotrexate was introduced in 1948 with the 
history of initial report by Sidney farber and the 
successful aminopterin, is an anti-folate in the 
treatment of child leukemia [10]. It is a synthetic folic 
acid analogue, which inhibit the enzyme 
dihydrofolate reductase and prevent conversion of 
dihydrofolate to tetrahydrofolate [11,4]. Methotrexate 
compete with the folic acid and interfere cell 
replication. Methotrexate was invented as a second 
drug of folic acid analogue from the study of folic acid 
deficient diets were shown to be declined in leukemic 
cell count and it was first used in ectopic pregnancies 
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in 1960, also it is an antimetabolite used in 1980 for 
the treatment of the ectopic pregnancy, by the 
extension of its use in gestational trophoblastic 
neoplasia [11,3]. Methotrexate have a structure similar 
to the folic acid and it is used in leukemia, neoplasia, 
and lymphomas [11] 
Systemic route of administration of methotrexate 
was highly effective, mainly IM route for the 
treatment of the ectopic pregnancies [8]. Methotrexate 
have an immunomodulatory action in autoimmune 
disease, it may cause teratogenicity while using this 
on the first trimester of the pregnancy [11]. 
Methotrexate have a teratogenic effect in ectopic 
pregnancy during presence of cardiac activity, it have 
an action in skin related problem and also have 
function in autoimmune condition. Their treatment is 
associated with the beta human chorionic 
gonadotropin [2,8]. They are contraindicated in case of 
rising beta hcg, they are act in rapidly growing cells 
[4]. A proper follow up should be considered before 
using methotrexate because it have some risk factors 
include renal impairment and hepatic impairment, it 
is not used in the case of presence of cardiac activity.it 
shows a relatively contraindicated in pregnancy of 
unknown location (PUL)[12]. The incidence of ectopic 
pregnancy is about 1-2% in developed countries [3]. 
Methotrexate: Methotrexate is a folic acid 
antagonist, which is invented as an anticancer agents, 
it inhibit rapidly dividing cells includes trophoblastic 
cells [2]. Primarily it is used for the treatment of acute 
lymphoblastic leukemia [11]. Methotrexate is a 
derivative of aminopterin, is an analogue of folic acid 
also its antimetabolite [13]. It is isolated from spinach 
leaves and called folic acid [15]. Now a days it is also 
used for pregnancy related conditions include ectopic 
pregnancies and trophoblastic leukemia, 
methotrexate is available in oral and systemic route, 
methotrexate is used as the first line treatment for the 
ectopic pregnancies, systemic methotrexate can be 
given in single-, double-, and multi-dose protocols 
depending on the clinical findings and beta-human 
chorionic gonadotropin (β-hcg) values [14]. 
Methotrexate have a structure similar to the folic 
acid. Methotrexate is used in ectopic pregnancy in 
1980 by the extension of its use in gestational 
trophoblastic neoplasia [11,3]. The recent study shows 
methotrexate is safe and effective in unrupted ectopic 
pregnancies [6,8]. Methotrexate is given with surgical 
management or it is used as the first line agent in case 
of unruptured ectopic pregnancies, recent studies 
shows the result of failure of the use of oral 
methotrexate compared with systemic use in ectopic 
pregnancies [3]. 
Mechanism of action of methotrexate: It is a folic 
acid antagonist.it inhibit the enzyme dihydrofolate 
reductase by interfering the DNA synthesis, hence 
conversion of dihydrofolate to trihydrofolate is 
prevented [9,11]. 
 
Figure 1: Mechanism of methotrexate in ectopic preg-
nancy 
It is essential for the denovo synthesis of purines 
nucleotides and thymidilate (essential substrate of 
the DNA synthesis, repair, and cell proliferation). 
Tetrahydrofolates have an essential role in synthesis 
of DNA and RNA precursors such as purines and 
pyrimidines [11]. Mainly it affect the s phase of the cell 
cycle and it works rapidly in dividing cells mainly 
trophoblastic cell, and the methotrexate have 
nonspecific mechanism of action and shows some 
side effects[2].  
Indications: Methotrexate was invented as a folic 
acid analogue for the treatment of acute 
lymphoblastic leukemia and is used to treat 
cancerous and non-cancerous conditions, Folic acid 
deficient diets were shows to decrease in leukemic 
cell count and this leads to the development of the 
folic acid analogue methotrexate as second drug, have 
an immunomodulatory action in rheumatoid 
arthritis, psoriasis [11]. Methotrexate is also used as 
the management for the autoimmune diseases such 
as rheumatoid arthritis, juvenile dermatomyositis, 
lupus erythematosus, sarcoidosis, Crohn's disease, 
some types of severe eczema and a wide range of 
forms of vasculitis [16,17]. Now a days it is also used for 
pregnancy related conditions include ectopic 
pregnancies and trophoblastic leukemia, 
Methotrexate is used for the treatment of 
chorioadenoma destruens, gestational 
choriocarcinoma [11]. 
It is used for the management of ectopic pregnancies 
with the combination of other surgical treatment. 
Methotrexate is used in the treatment of breast 
cancer, epidermoid cancers of the head and neck and 
lung cancer, particularly squamous cell and small cell 
types used alone or in combination with other 
anticancer agents [18]. It is also used in advanced stage 
non-Hodgkin’s lymphomas, It is used in the treatment 
of a choriocarcinoma by the application of this drug 
in women in 1956[11]. Methotrexate is used a 
combination treatment with other 
immunosuppressive drugs, primarily in combination 
with biologics, In such cases, methotrexate is 
responsible for inhibition of formation of antibodies 
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against biologic drugs, thereby increasing their 
efficacy[13].It is widely used in ophthalmology ,mainly 
in uveitis, scleritis also in advanced diabetic 
neuropathy [19]. 
Contraindication: Methotrexate is contraindicated 
in pregnant women with psoriasis, rheumatoid 
arthritis also it is contraindicated in the case of the 
nursing mother and in children but this can use in the 
case of the cancer related condition in pediatrics[18].It 
should be avoided in increased level of serum 
creatine and also in liver transaminase 
contraindicated in the case of psoriasis and in case of 
rheumatoid arthritis with alcoholism and absolutely 
contraindicated in the case of the 
immunosuppressive syndrome with bone marrow 
hypoplasia, leukopenia, thrombocytopenia and 
significant anemia, pulmonary disease, renal disease, 
Active pelvic disease, intrauterine pregnancies, 
ruptured ectopic pregnancies and hemodynamically 
unstable patients and relatively contra indicated in 
the high initial hcg level and also in embryonic 
cardiac activity is detected by transvaginal ultra 
sonography, Adrenal mass>4, these 
contraindications limits the use of methotrexate use 
in various conditions[20]. Methotrexate is 
contraindicated in the case of the chronic liver 
disease (methotrexate should be toxic to the 
hepatocytes) and in immunodeficiency condition [4].  
Side effects: The side effect of methotrexate is based 
on the patient conditions. Commonly side effects are 
no occur in all patients using methotrexate. Serious 
side effects occurring on the basis of the dosage 
regimen. Sometimes it may cause serious side effects 
and its over dose may cause its toxicity in patient 
receiving methotrexate, high dose intake of it also 
cause severe life threatening condition. Methotrexate 
acts in rapidly dividing cells, by this mechanism it 
may cause the hematological (megaloblastic anemia, 
thrombocytopenia, pancytopenia, leukopenia), 
dermatological symptoms (burning sensation, 
ulceration to the mucosa, urticarial, erythema, 
photosensitivity, vasculitis) and gastro intestinal 
symptoms may occur at high or low dose (nausea, 
vomiting diarrhea, abdominal pain), sometimes it 
may cause toxic symptoms like neutropenia, nausea 
vomiting, diarrhea, git inflammation, 
hypersensitivity reactions occurs[11,20,21]. 
Methotrexate causes teratogenic effects while it’s 
using during first trimester of the pregnancy [11]. 
Hepatotoxicity is the most common cause of the use 
of the methotrexate also It may cause renaltoxicity 
(acute renal failure, tubular necrosis), neurotoxicity 
may occur due to the systemic administration of 
methotrexate (insomnia, cerebral dysfunctions, 
confusion, seizure, agitation), pulmonary toxicity- 
most serous one and, may occurring at low dose 
(pneumonitis, alveoitis, no productive cough, 
dyspnea, malaise). The side effects may reduce by the 
use of leucoverin (is similar to the folinic acid) [21,20]. 
Dosage and administration: Methotrexate is 
administered though oral route as well as systemic 
route, in ectopic pregnancy methotrexate is treated 
through Intra muscular route, this route is most 
widely accepted treatment in ectopic pregnancy also 
it is used as an alternative to the surgical 
treatment[22]. Methotrexate dosage regimen is 
available in different form, which is different for each 
patients based on their condition as well as Modern 
treatment is safe with the use of systemic 
methotrexate, differnt dosage regimen is available for 
the ectopic pregnancy- Single dose (50mg/m²), 
double dose(50mg/m²) and multi dose regimen with 
{1mg/kg and is treated with 0.1mg/kg leucoverin (is 
a folinic acid, it is an active form and is used only with 
the multiple dose and not in single use of 
methotrexate )} [14,4]. 
Pharmacokinetics: Methotrexate is absorbed 
through intra muscular route or oral route with 
smaller dose less than 30 mg/m2 and decreased 
absorption while receiving dose greater than 80 
mg/m2, after I.V administration initial volume of 
distribution is about 0.18L/kg and steady state 
volume is approximately 0.4-0.8L/kg and 
metabolized through hepatic intercellular membrane 
,it forms polyglutamated form that block enzyme 
reductase and thymidylate synthatase,itsoral dose is 
metabolized by the intestinal bacteria, elimination 
half-life is from 6-69 hrs and they are eliminated 
through renal excretion and plasma clearance 
become saturated at high dose (20g), high dose 
administration cause the presence of small amount of 
thyoxymethotrexate, its clearance is decreased by the 
administration of salicylates like organic acid 
methotrexate is poorly penetrate cell membrane by 
carrier mediated transport mechanism and it does 
not penetrate blood - cerebro spinal fluid barrier, the 
absorption rate of methotrexate is different for 
different patients, the recent studies shows that intra 
muscular methotrexate is effective compared to the 
oral methotrexate [18,22]. 
Drug interactions: Methotrexate having some 
interactions with certain vaccines, drugs and other 
product. Some drug cause a serious interactions with 
mqthotrexate. some have mild and moderate 
interactions, certain vaccines and drugs that cause 
severe interactions with methotrexate are given 
below [23,24]: 
• Influenza A virus vaccine, Rubella vaccine, 
Varicella vaccine, Polio virus vaccines, Measles, 
mumps, Rotavirus vaccine, Typhoid vaccine, 
Small pox vaccine and Yellow fever vaccine and 
Acitretin. 
• Some mild interaction with methotrexate 
includes: Folic acid, Adalimumab, l-methylfolate, 
Golimumab, Hydrochlorothiazide, 
Methychlothiazide. 
• Other drug includes: Chloramphenicol, 
Leflulomide. 
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Azathioprine, Sulfasalazine - cause liver 
problems 
Retinoid – Isotretinoin 
Penicillin, Probencid, phenytoin 
PPI- Pantoprazole, Omeprazole, 
Esomeprazole. 
Ectopic pregnancy 
Ectopic pregnancy is defined as implantation and 
subsequent development of the zygote at a site other 
than normal intrauterine cavity [25]. The most 
common site of ectopic pregnancy is the fallopian 
tube other sites include ovary, abdomen and cervix, 
methotrexate is select as the medical treatment for 
this condition. Recently methotrexate is usually used 
in the stable women having unruptured pregnancy. 
The case of ectopic pregnancy is increased day to day. 
The existing treatment for the ectopic pregnancy is 
surgical management and the medical management 
with systemic methotrexate. whie using this 
medication human chorionic gonadotropin [hcg] 
should be considered, it is also an important factor 
before using the methotrexate, the most common 
complication of ectopic pregnancies include rupture, 
internal bleeding and this may be the cause of 
hypovolemic shock., in ectopic pregnancy the most 
common cause leading to maternal death [6]. 
Clinical manifestations 
The clinical manifestations of ectopic pregnancies are 
abnormal bleeding amenorrhea and abdominal pain, 
pelvic inflammatory disease, and spontaneous 
abortion, vaginal spotting may see in first trimester of 
ectopic pregnancies [6]. Less common symptoms 
include shoulder pain, dizziness, weakness, fainting. 
other symptoms include urinary symptoms and 
rectal pressure, women who experienced ectopic 
pregnancy have may have a variations in their 
menstrual periods, pain and bleeding in women at 
first trimester of their pregnancy[8,6]. 
Hemodynamically unstable patient may experience 
the syncope and the signs include shock, tachycardia 
on ruptured ectopic pregnancy [6]. 
Causes and risk factors: A fertilized egg have 
difficulty to passing through ruptured tube and this 
will leads to the growing and implant the egg in tube 
this will leading to ectopic pregnancy, ruptured 
ectopic pregnancies cause hemorrhage and shock 
these are the leading cause of maternal mortality in 
the first trimester, most tubal pregnancies are caused 
by tubal obstruction or delayed passage of the 
fertilized ovum [6] other causes include [8]: 
• Cigarette smoking 
• Tubal damage 
• Previous surgery 
• Chlamydia trachomatis infection. 
Women who experienced ectopic pregnancy have 
may have a variations in their menstrual periods, 
pain and bleeding in women at first trimester of their 
pregnancy, hemodynamically unstable patient may 
experience the syncope and the signs include shock, 
tachycardia on ruptured ectopic pregnancy [6,8]. Other 
symptoms of ectopic pregnancies are infertility, 
contraceptive failure and previous ectopic pregnancy 
[3]. A ruptured ectopic pregnancy should be strongly 
suspected if a woman has a positive pregnancy test 
and having syncope and signs of shock including, 
pallor and collapse, tachycardia, there may be 
abdominal distension and tenderness may occur, 
while a bimanual examination may reveal 
tenderness, cervical excitation and an adnexal mass, 
great caution is required as this may exacerbate 
bleeding, in an emergency, where the patient has 
collapsed and there is high clinical suspicion of tubal 
rupture [26].  
Other Risk factors include: previous surgery, 
endometriosis, previous ectopic pregnancy, 
intrauterine device, infertility treatment, mechanical 
factor infertility, longer stimulation [26,27]. 
Diagnosis: 
• History and physical examination 
• Speculum and binomial examination 
• Trans vaginal ultra-sonography 
• Measurement of beta hcg 
Diagnosis of ectopic pregnancies were difficult. 
Sometimes there will be a misdiagnosis in this case [8]. 
Usually it is diagnosed in the first trimester of their 
pregnancies, personal history and physical 
examination is the initial diagnosis of ectopic 
pregnancy. Abdominal pain with spotting occur in 6 
to 8 weeks after a last normal menstrual period is 
symptom of tubal pregnancy [28]. Speculum and 
bimanual examination have limited role in diagnosis, 
pregnancy test is positive in ectopic pregnancy, early 
diagnosis is with algorithms which are based on high 
resolution transvaginal ultrasound (TVS) and 
quantitative estimation of serum βhcg measured 
initially and changes in the levels of βhcg can be used 
to predict ectopic pregnancy [25]. Ultra sound 
evaluation is the main used to diagnose the ectopic 
pregnancy, and these ultrasound result should be 
combined with the qualitative beta subunit of human 
chorionic gonadotropin levels [29,3]. Hemodynamically 
unstable women who experienced syncope and signs 
of tachycardia and the shock should be a diagnosis of 
the ruptured ectopic pregnancies, an ectopic 
pregnancy is diagnosed by the presence of an adnexal 
mass in absence of intrauterine gestation sac, often 
visible within the Fallopian tube [26]. Detection of an 
extrauterine gestational sac containing a yolk sac 
confirms the ectopic pregnancy [30]. If a patient has a 
βhcg level with 1,500 mIU/mL or greater and 
transvaginal ultrasonography does not show an 
intrauterine gestational sac indicates ectopic 
pregnancy should be suspected [31]. It is better tool to 
identify the non-tubal, ectopic pregnancy, also 
ectopic pregnancy is diagnosed by using serum 
progesterone level, if it is < 5ng/ml indicates an 
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abnormal pregnancy and greater than 20ng/ml 
usually indicates abnormal intrauterine 
pregnancy[12]. 
 
Figure 2: Transvaginal ultra-sonography of ectopic 
pregnancy 
Beta HCG and ectopic pregnancy, methotrexate 
The body release HCG during the period of 
pregnancy, human chorionic gonadotropin is a 
hormone produced by the syntiotrohoblastic cell of 
placenta during pregnancy, and smaller amounts are 
produced from the pituitary gland, colon and liver, 
the hormone is a glycoprotein having two subunits, 
one alpha and beta [32]. Beta human chorionic 
gonadotropin is an important test for the diagnosis of 
ectopic pregnancy. Its level is different in different 
patient, some women having ectopic pregnancy with 
increased initial level of beta subunit of hcg and some 
have decreased level of human chorionic 
gonadotropin. Methotrexate is highly beneficial to the 
patient have a decreased β hcg level but in increased 
level of beta hcg patient were failure to methotrexate 
treatment [3]. Serum β hcg level should detected with 
investigation of ultrasonography in the first trimester 
of pregnancies [31]. 
• A low hcg level is a sign of an ectopic 
pregnancy [32,8]. 
• The level of hcg stop rising and dropping 
indicates – miscarrying [8] 
Serum beta hcg is detected urine or blood, also in an 
emergency situation, it is detected from serum or 
urine. In serum test the detected level of hcg is lower 
than 5IU/L and in urine test the detected level of hcg 
is from 20-50 IU/L IF a serum concentration is lower 
than 1000 IU/L indicates a risk of an ectopic 
pregnancy which means risk of ectopic pregnancy is 
associated with the level of the human chorionic 
gonadotropin. Ectopic pregnancy is presents with 
increased or decreased level of the hcg level, thus the 
measurement is most useful in ectopic pregnancy, 
and is used for the women who have bleeding and 
pain in first trimester[30,26]. 
Ectopic pregnancy is suspected if the transvaginal 
ultrasonography shows no intra uterine gestational 
sac when increased level of hcg, if the beta hcg plateau 
fails to double in 48hr, and the ultrasound 
examination was fail to identify an intra-uterine 
gestational sac [8]. Some studies shows the prove of 
methotrexate treatment reduced the beta hcg level 
and some shows the methotrexate is effective in 
hemodynamically stable unruptured ectopic 
pregnancies [6,30]. Ectopic pregnancy have an 
expectant management with low hcg level [33]. In 
methotrexate management serum beta hcg level 
should be monitoring closely.it is time consuming 
and not detect in night and evening [30]. Serum 
progesterone measurement is used as an adjunct to 
serum hcg measurement [8,12]. 
Treatment and management of ectopic pregnancy 
The management of ectopic pregnancy include [5, 26, 6, 
8, 31]: 
• Surgical management  
• Expectant management 
• Medical treatment 
In surgical management there exist two different 
methods:  
1. Radical – salpingectomy 
2. Conservative-salpingostomy, salpingectomy, 
segmental resection, milking or fimbria 
expression. 
Medical treatment:  
1. Systemic - methotrexate  






In earlier ectopic pregnancies were treated with the 
surgical treatment, although in several conditions 
there is an evidence of failure rate of surgical 
pregnancies are occurred due to its complications, 
women who experienced ectopic pregnancy treated 
with surgical pregnancy they have a future infertility 
problem and have a complication of infections and 
other complications are occurred[2]. In several cases 
surgical treatment along with methotrexate have 
successful rate in patients who have an ectopic 
pregnancy [8]. Modern studies prove that the patients 
with ectopic pregnancies are primarily treated with 
methotrexate, after that they are further treated with 
surgically if necessary [2]. The main treatment are yet 
to be known is surgical treatment and medical 
treatment with systemic methotrexate [2]. 
Surgical method include salpingectomy but it cause 
future fertility problem and have a history of 
complications in some patients who experienced 
ectopic pregnancies [2]. Surgical treatment is done in 
ruptured condition of ectopic pregnancy, 
salpingectomy is the surgical removal of fallopian 
tube, it is recommended if fertility is not desired or 
presence of uncontrolled bleeding and salpingostomy 
is the creation of opening into the fallopian tube, 
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pregnancy issue is removed and tube is flushed [12]. 
Salpingectomy have a risk of infertility in women 
carrying ectopic pregnancy. In some case include 
hemodynamically unstable and heterotopic 
pregnancies, symptoms (pain), diagnostic 
laparoscopy, and women who have high hcg level 
require surgery and laparoscopy is an effective 
approach and management, Laparoscopy is done in 
case of extrauterine pregnancy and laparotomy is 
performed only if the laparoscopy is not possible 
conditions [34]. Indication of salpingectomy includes 
tubular distribution ipsilateral recurrence, prior 
ipsilateral sterilization [1]. 
Laparoscopy is another method in surgical treatment. 
Laparoscopy is also known as diagnostic laparoscopy, 
it is a diagnostic procedure to identify an organ inside 
the abdomen it requires only small incision 
compared to another, and it is most widely used 
surgical treatment, laparoscopy is associated with the 
risk of bleeding, infection, and having several 
complications include anesthesia problem, blood clot, 
rarely cough, abdominal pain, anxiety, anemia, mild 
bleeding or infection, fever, urinary tract infection, 
postoperative urinary retention, and ileal paralysis, 
also occurred, laparotomy is performed only if 
laparoscopy is not done or possible, they have less 
blood loss [34]. This will leds to the invention of 
medical treatment, mainly methotrexate is given as 
the medical treatment for the ectopic pregnancy. A 
laparoscopic salpingostomy should be considered if 
future fertility is desired in patients have tubal 
pregnancy [26]. 
Medical treatment of ectopic pregnancy 
Methotrexate is an anticancer drug It also under the 
classification of DMARDs and also it plays an 
important role in dermatology, methotrexate is first 
used for the treatment of ectopic pregnancy in 
1982[4]. Criteria for the use of methotrexate 
includes[1]: 
• Hemodynamically stable patient 
• β hcg5000mIU/L 
• Adrenal mass; 4cm 
• No tubular damage 
Pretreatment should be done before the usage of 
methotrexate, it mainly include blood typing, sr.hcg, 
and lab test (CBC, LFT mainly ALT/AST, creatine, 
RFT), methotrexate mainly act in rapidly 
proliferating cells. It is available in oral, injection, and 
powder methotrexate, mainly systemic route is 
highly recommended for treatment of ectopic 
pregnancy, most common protocols include single 
and multi-dose regimens, single dose is given as 
50mg/m2 and multi dose is given in 1mh/kg based on 
the ectopic pregnancy protocol of university of 
Alabama at Birmingham shows 90% of success rate 
in ectopic pregnancy treated with methotrexate in 
patients with 5000mlU/mL based on modern 
protocol methotrexate is exact use in 
hemodynamically stable with unruptured mass 
women with ectopic pregnancy[12]. In majority of the 
case single dose regimen is used but it shows more 
failure rate, with use of this and special care to be 
taken in patients with 5000mlU/mL and presence of 
cardiac activity, in this case methotrexate is relatively 
contraindicated, several recent studies are yet to be 
known methotrexate is safe on comparing with the 
surgical studies with a proper follow up should be 
considered before and after the use of methotrexate 
[4,8,12,]. 
Treated with systemic methotrexate have success 
rate compared to oral methotrexate. Failure rate of 
systemic methotrexate increases with raising β hcg, 
systemic methotrexate have some benefits and 
tolerability compared to other form. It is shown to be 
a good alternative to laparoscopy an important 
criteria is β hcg for ectopic pregnancy. Most recent 
studies shows a failure rate in single dose protocol for 
unruptered ectopic pregnancies [3]. Two dose and 
multi doses are administered in people with high 
initial β hcg, methotrexate is absolutely 
contraindicated in presence of cardiac activity during 
ectopic conditions [1]. Success rate of methotrexate 
decreasing by increasing βhcg >5000 shows failure to 
methotrexate with single dose treatment. A single 
dose regimen of methotrexate is used to minimize the 
side effects and low cost, to avoid risk problems [3]. 
Multi dose or two dose should give only in high β hcg 
condition but they are relatively contraindicated in 
many of the case of single dosage regimen of 
methotrexate have success rate of 65% compare with 
the surgical treatment of 35% success rate based on 
the literature review of Oman journal of obstetrics 
and gynecology, based on this single dose protocol is 
administered with a 50mg/m² methotrexate in day 1 
and they performed a serial βhcg on 4th and 7th day, 
the β hcg level is declined 15% compared with 4th day 
then after they undergo follow up until undetected 
hcg level a second dose of 50 mg/m2 methotrexate is 
given to the patient with βhcg level on 7th day was 
same higher than 4th day. This proven that the single 
dose methotrexate have successful rate in βhcg level 
become negative [2.]  
The single dose protocol should follows the condition 
include [2, 12]: 
• Hemodynamically stable patients 
• β hcg <5000mIU/mL 
• Presence of peritoneum <100ml 
• Adrenal mass<4cm 
• No sign of cardiac activity. 
The selected criteria of candidates are exclude from 
[2]  
• Hemodynamically unstable patients 
• βhcg >5000mIU/mL 
• Peritoneum>100ml 
• Adrenal mass >4cm 
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Several studies have some different approach and 
suggestions, most of the systematic review used 
different trials in protocol of single, two dose or 
multiple doses shown in (Table 1) [12].  
Multi dose risk is compensate with the leucoverin 
0.1mg/kg, is a folinic acid to counteract the folic acid 
antagonist side effects and impairment, total success 
rate is increased with βhcg <5000 mIU/L, proper 
follow up should be done to identified the treatment 
effect and side effect, other treatment guidelines 
include[12,8]: 
• Advised the patient to avoid NSAIDs and 
alcohol. 
• Avoid the pelvic examination or pelvic 
intercourse during treatment. 
• Weekly follow up of βhcg. 
CONCLUSION 
Methotrexate is proven to be most effective and safe 
for unruptured ectopic pregnancy. Tubular damage 
cause increased the risk of methotrexate. This review 
article shows a single dose is beneficial to 
unruptured, stable patients with low beta hcg level 
and is effective with minimize the side effects 
compared to other multi or two dosage regimen. 
Multiple dosage regimen is proven to be effective in 
high initial beta hcg level that is >5000mIU/mL. A 
systematic follow up should be done in case medical 
treatment with methotrexate. Methotrexate is 
confirm used in ectopic pregnancy also it is used as 
an alternative to surgical treatment. Ectopic 
pregnancy is treated in various dosage regimen based 
on the hcg level and selection criteria of candidates. 
Hemodynamically stable women is treated with the 
systemic methotrexate. Systemic route is mainly 
intramuscular route is very effective in ectopic 
pregnancy. 
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